𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation

✍ Scribed by Frank Pietruck; Andreas Kribben; Truyen Ngo Van; Daniel Patschan; Stephan Herget-Rosenthal; Onno Janssen; Klaus Mann; Thomas Philipp; Oliver Witzke


Book ID
110916324
Publisher
Springer
Year
2005
Tongue
English
Weight
60 KB
Volume
18
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Is there a link between hepatitis C viru
✍ Paul J. Thuluvath πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 65 KB

New-onset diabetes mellitus (NODM) is seen in 10-30% of renal and 9-21% of liver transplant recipients. [1][2][3][4][5][6][7][8][9][10][11][12][13][14] Older age, black race, obesity, hepatitis C virus (HCV) infection, family history of diabetes mellitus (DM), and use of tacrolimus or corticosteroid